Skip to main content

Beneficial ownership — 13D / 13G

87,281 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Palo Alto Investors LP RVNC Revance Therapeutics, Inc. 13G/A 5.96% 2y
Alger Associates, Inc. 13-3017981 TRNS Transcat Inc 13G/A 8% 2y
PRICE T ROWE ASSOCIATES INC /MD/ IR Ingersoll Rand Inc. 13G/A 5.7% 2y
RTW INVESTMENTS, LP STOK Stoke Therapeutics, Inc. 13G/A 9.3% 2y
Sculptor Capital LP ELIQ Electriq Power Holdings, Inc. 13G/A 0% 2y
Radcliffe Capital Management, L.P. SHAP Spree Acquisition Corp. 1 Limited 13G/A 0% 2y
ARMISTICE CAPITAL, LLC CFRX ContraFect Corporation 13G/A 9.99% 2y
GREAT POINT PARTNERS LLC ZURA Zura Bio Ltd 13G/A 7.56% 2y
GREAT POINT PARTNERS LLC VTGN Vistagen Therapeutics, Inc. 13G/A 9.99% 2y
MAVERICK CAPITAL LTD ATRA Atara Biotherapeutics, Inc. 13G/A 0% 2y
CADIAN CAPITAL MANAGEMENT, LP PLNT Planet Fitness, Inc. 13G 5.2% 2y
Route One Investment Company, L.P. HLF Herbalife Ltd. 13G/A 10.4% 2y
Walleye Capital LLC MOBQ Mobiquity Technologies, Inc. 13G/A 0% 2y
Cubist Systematic Strategies, LLC ACAC Acri Capital Acquisition Corporation Class A Common Stock 13G/A 0% 2y
EcoR1 Capital, LLC CNTA Centessa Pharmaceuticals plc 13G/A 5.8% 2y
Joshua G. James HUCK Huckleberry.ai, Inc. 13G/A 11.6% 2y
Aristotle Capital Management, LLC OSK Oshkosh Corp 13G/A 10.08% 2y
EVe Mobility Sponsor LLC EVE EVe Mobility Acquisition Corp 13G/A 59.7% 2y
NOMURA HOLDINGS INC MBAC M3-Brigade Acquisition II Corp. 13G/A 0% 2y
David Velez Osorno NU Nu Holdings Ltd. 13G/A 20.8% 2y
Fairmount Funds Management LLC ELVN Enliven Therapeutics, Inc. 13G/A 5.2% 2y
Elon R. Musk TSLA Tesla, Inc. 13G/A 20.5% 2y
AMERIPRISE FINANCIAL INC SMTC Semtech Corp 13G 8.03% 2y
AMERIPRISE FINANCIAL INC HBB Hamilton Beach Brands Holding Co 13G 6.82% 2y
D. E. Shaw & Co., L.P. JAQC Jupiter Acquisition Corporation Common stock 13G/A 0% 2y
ARMISTICE CAPITAL, LLC CNSP CNS Pharmaceuticals, Inc. 13G/A 9.99% 2y
AWM Investment Company, Inc. PFIE Profire Energy, Inc 13G 5.5% 2y
Clal Insurance Enterprises Holdings Ltd FORTY Formula Systems (1985) Ltd 13G/A 5.3% 2y
Balyasny Asset Management L.P. BURU Nuburu, Inc. 13G 0% 2y
Caledonia (Private) Investments Pty Ltd UDMY Udemy, Inc. 13G/A 6.16% 2y
Energy Income Partners, LLC PAGP Plains Gp Holdings LP 13G/A 5.8% 2y
Deep Track Capital, LP AGEN Agenus Inc 13G/A 8.31% 2y
Walleye Capital LLC VGAS Verde Clean Fuels, Inc. 13G 6.99% 2y
PERCEPTIVE ADVISORS LLC ADMA Adma Biologics, Inc. 13G/A 2.8% 2y
Divisadero Street Capital Management, LP RRGB Red Robin Gourmet Burgers Inc 13G/A 0% 2y
Shaolin Capital Management LLC CHAA Catcha Investment Corp 13G 7% 2y
T. Rowe Price Investment Management, Inc. JBGS JBG SMITH Properties 13G/A 0% 2y
MARSHALL WACE, LLP CNDA Concord Acquisition Corp II 13G/A 0% 2y
MARSHALL WACE, LLP LOCC Live Oak Crestview Climate Acquisition Corp. 13G/A 0% 2y
Lynx1 Capital Management LP CCCC C4 Therapeutics, Inc. 13G/A 6.4% 2y
CADIAN CAPITAL MANAGEMENT, LP CYRX Cryoport, Inc. 13G 7.1% 2y
AMERIPRISE FINANCIAL INC KTB Kontoor Brands, Inc. 13G/A 3.64% 2y
AQR CAPITAL MANAGEMENT LLC FORL Four Leaf Acquisition Corporation Class A Common Stock 13G 8.49% 2y
SPROTT INC. MAG MAG Silver Corp. 13G/A 3% 2y
FIR TREE CAPITAL MANAGEMENT LP CPTKW Crown PropTech Acquisitions 13G 9.13% 2y
Forager Fund, L.P. EML Eastern Co 13G/A 7.5% 2y
Redpoint Omega II, LLC HCP HashiCorp, Inc. Class A Common Stock 13G/A 4.4% 2y
FIR TREE CAPITAL MANAGEMENT LP ACAH Atlantic Coastal Acquisition Corp. Class A Common Stock 13G/A 6.61% 2y
Rosalind Advisors, Inc. MDWD MediWound Ltd. 13G/A 5.2% 2y
T. Rowe Price Investment Management, Inc. LFUS Littelfuse Inc 13G 5.7% 2y